# US 2025/0084371 A1 · Cell monolayer blocking agents and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084371 A1
- Document ID: US20250084371A1
- Status: Published application
- Kind: A1
- Application number: 18/725,497
- Filed: 2022-12-29
- Published: 2025-03-13
- Earliest claimed: 2021-12-31
- Applicants: Lumicks Ca Holding B.V.
- Inventors: Domenico FASCI; Marinus Theodorus Johannes VAN LOENHOUT; Trillian Ashley GREGG; Serena Alba DAVOLI; Mattijs DE GROOT
- Web page: https://patentgrep.com/patent/US20250084371A1

## CPC

- C12N 5/0602: {Vertebrate cells}
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C12N 2502/1114: T cells
- C12N 2502/30: tumour cells
- C12N 2510/00: Genetically modified cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The current invention relates to cell-cell interaction and in particular to cellular avidity. Provided are improved means and methods to study cell-cell interaction and characterizing cellular avidity. When target cells were prepared on a coated surface, and subsequently allowed to interact with cells, background binding can be observed. The current inventors sought to improve, i.e. reduce, background binding and found highly advantages blocking compounds that are an improvement over blocking compounds commonly used.

## Claims

### Claim 1

A method for preparing target cells attached to a coated surface, comprising the steps of:
providing target cells attached to a surface coated with a polypeptide;
providing an NHS ester reagent;
blocking the target cells attached to the coated surface with the NHS ester agent.

### Claim 2

A method for preparing target cells attached to a coated surface, comprising the steps of:
providing a surface coated with a polypeptide for attachment of target cells;
providing target cells;
providing an NHS ester reagent;
contacting the target cells with the coated surface and allowing the target cells to attach to the coated surface;
blocking the coated surface with attached target cells with the NHS ester agent.

### Claim 3

A method for preparing target cells attached to a coated surface, comprising the steps of:
providing a surface for attachment of target cells;
providing target cells;
provide a polypeptide for coating;
providing an NHS ester reagent;
coating the surface with a polypeptide to provide a coated surface;
contacting the target cells on the coated surface and allowing the target cells to attach to the coated surface;
blocking the target cells attached to the coated surface with the NHS ester agent.

### Claim 4 (depends on 1)

The method in accordance with claim 1, wherein the NHS ester agent is a PEG-NHS ester.

### Claim 5 (depends on 4)

The method in accordance with claim 4, wherein the PEG-NHS ester agent is a BS(PEG)n or MS(PEG)n.

### Claim 6 (depends on 5)

The method in accordance with claim 5, wherein BS(PEG)n is BS(PEG)5 or BS(PEG)9 or wherein MS(PEG)n is MS(PEG)4.

### Claim 7 (depends on 1)

The method in accordance with claim 1, wherein the coating is selected from the group consisting of fibronectin, poly-L-lysine, poly-D-lysine, poly-L-ornithine, laminin, collagen, fibronectin, fibrinogen, vitronectin, and osteopontin.

### Claim 8 (depends on 1)

The method in accordance with claim 1, wherein the provided surface for attachment is a glass surface, preferably a glass surface in a chip.

### Claim 9 (depends on 1)

A method for determining cellular avidity comprising:
providing target cells attached to a coated surface as defined in claim 1,
providing cells of interest;
incubating the target cells attached to the coated surface with the provided cells of interest; and
determining the cellular avidity of the cells of interest with the target cells.

### Claim 10 (depends on 9)

The method in accordance with claim 9, wherein control cells of the target cells or the cells of interest are provided and the cellular avidity determined thereof as well.

### Claim 11 (depends on 9)

The method in accordance with claim 9, wherein the cellular avidity is determined by exerting an acoustic force, shear flow or a centrifugal force.

### Claim 12 (depends on 9)

The method in accordance with claim 9, wherein a candidate agent is provided for modulating the cellular avidity between a cell of interest and a target cell, and wherein said agent is present in the incubation step.

### Claim 13 (depends on 12)

The method comprising the steps in accordance with claim 12, for the screening of candidate agents.

### Claim 14 (depends on 1)

Method for sorting and/or screening of cells of interest comprising the steps of:
providing target cells attached to a coated surface as defined in claim 1,
providing cells of interest;
incubating the cells of interest with the target cells attached to the surface;
applying a force on the cells of interest
selecting and/or sorting cells of interest that have detached and/or that remain attached to the target cells.

### Claim 15 (depends on 9)

Method in accordance with claim 9, wherein the cells of interest are effector cells.

### Claim 16 (depends on 1)

Use of an NHS ester reagent in a blocking reaction in a method in accordance with claim 1.
